Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use

BACKGROUND: Oral polio vaccine (OPV) containing attenuated serotype 2 polioviruses was globally withdrawn in 2016, and bivalent OPV (bOPV) containing attenuated serotype 1 and 3 polioviruses needs to be withdrawn after the certification of eradication of all wild polioviruses to eliminate future ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Duintjer Tebbens, Radboud J., Hampton, Lee M., Thompson, Kimberly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892013/
https://www.ncbi.nlm.nih.gov/pubmed/29631539
http://dx.doi.org/10.1186/s12879-018-3074-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892013/
https://www.ncbi.nlm.nih.gov/pubmed/29631539
http://dx.doi.org/10.1186/s12879-018-3074-0

Ejemplares similares